BSE filing, NSE: UCOBANK. Summary written from the filing by ALFA Finder's alert engine.
UCO Bank: key numbers
- Share price
- ₹22.07
- Market cap
- ₹27,675 Cr
- Revenue (annual)
- ₹26,281 Cr
- Net profit (annual)
- ₹2,768 Cr
- P/E (TTM)
- 9.3×Sector 19.7×
- Promoter holding
- 90.95%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UCO Bank
All →UCO Bank Management Change
UCO Bank's Central Government nominated Shri Mohamed Ashraf J S as a director, replacing Shri Hari Har Mishra, effective 23 October 2026. The filing gives the appointment details and confirms no SEBI debarment.
UCO Bank Results Update
UCO Bank reported Q2 FY27 net profit of Rs.786 Crore, up 26.77% Y-o-Y. Total business grew 18.81% Y-o-Y to Rs.6,37,280 Crore with NPA at 1.96%.
UCO Bank Investor Presentation: Key Takeaways
UCO Bank reported strong Q2 FY27 performance with Net Profit rising 26.77% YoY to ₹786 Cr. Focus remains on RAM segment growth and improving asset quality with NNPA at 0.18%.
- Call
- Guides 14% growth
UCO Bank Q2 FY27 Results: Net Profit ₹785.6 Cr, Up 26.8% YoY
UCO Bank reported revenue from operations of ₹7,286 Cr (+11.5% YoY) and net profit of ₹785.6 Cr (+26.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹785.6 Cr · +26.8% YoY
UCO Bank Board Meeting Date
UCO Bank will hold a board meeting on October 15, 2026, to consider and approve its unaudited financial results for the quarter and half-year ended September 2026.
UCO Bank Credit Rating
UCO Bank received a credit rating reaffirmation of 'AA/Stable' from India Ratings & Research Pvt Ltd for its long-term instruments aggregating to Rs. 1,500 Crore.
- Value
- ₹1,500 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.